Misleading Advertising of Health-Related Products in Ecuador during the COVID-19 Pandemic

Background Media coverage of the COVID-19 pandemic increased tuning ratings during this time. The aim of this study was to identify misleading advertising of health-related products on Ecuadorian television during the COVID-19 pandemic. Methods Television channels were monitored for 111 h in the months of June and October 2020. Verbal, nonverbal and context content were analyzed from each advertising spot according to ethical standards for the promotion of products for human health Results A total of 667 spots were analyzed. Most, 90%, involved misleading advertising of health-related products. Products for gastrointestinal conditions were the most publicized (17.8%) during the period analyzed. Newscasts most often advertised products intended to improve sexual potency (22.9%) and to a lesser degree those intended to prevent and treat respiratory problems (1.8%); this relationship was reversed when compared to general programming (p < 0.05). Conclusions Most of the health-related products advertised on Ecuadorian television are advertised misleadingly, with news programs having the highest number of such advertisements per hour of programming.

[1]  S. Olsson,et al.  Pharmacovigilance in low‐ and middle‐income countries: A review with particular focus on Africa , 2021, British journal of clinical pharmacology.

[2]  C. Blandizzi,et al.  The Impact of the COVID-19 “Infodemic” on Drug-Utilization Behaviors: Implications for Pharmacovigilance , 2020, Drug Safety.

[3]  Andreu Casero-Ripollés.  Impact of Covid-19 on the media system. Communicative and democratic consequences of news consumption during the outbreak , 2020 .

[4]  M. Segura.  Con alerta pero sin pánico. El rol de los medios durante la pandemia. , 2020, Revista de la Facultad de Ciencias Medicas.

[5]  J. Zarocostas.  How to fight an infodemic , 2020, The Lancet.

[6]  Lisa M. Schwartz,et al.  Medical Marketing in the United States, 1997-2016 , 2019, JAMA.

[7]  L. Bero,et al.  Ethical drug marketing criteria for the 21st century , 2018, British Medical Journal.

[8]  W. Shrank,et al.  Dangers and Opportunities of Direct-to-Consumer Advertising , 2018, Journal of General Internal Medicine.

[9]  Ludovic Revéiz,et al.  Publicidad y promoción de medicamentos: regulaciones y grado de acatamiento en cinco países de América Latina , 2011 .

[10]  Carmen Otero García-Castrillón,et al.  La problemática regulación comunitaria de los complementos alimenticios , 2007 .

[11]  S. Gilbody,et al.  Benefits and harms of direct to consumer advertising: a systematic review , 2005, Quality and Safety in Health Care.

[12]  Richard G. Wilkinson,et al.  Social Determinants of Health: The Solid Facts , 1998 .

[13]  Ana María Ullod.  Zapping y publicidad , 1994 .

[14]  Antonio Cruz.  El Rol de los Medios de Comunicación en la Pandemia del COVID-19 a Nivel Mundial , 2020 .

[15]  Mhs Joseph S. Ross MD,et al.  Direct-to-Consumer Broadcast Advertisements for Pharmaceuticals: Off-Label Promotion and Adherence to FDA Guidelines , 2017, Journal of General Internal Medicine.

[16]  M. Brucker.  Social Determinants of Health. , 2017, Nursing for women's health.

[17]  D. Kreling,et al.  Content Analysis of False and Misleading Claims in Television Advertising for Prescription and Nonprescription Drugs , 2013, Journal of General Internal Medicine.

[18]  Sonia Ester,et al.  Connotation and persuasion in the advertising image , 2008 .